Antialbuminuric effect of eplerenone in comparison to thiazide diuretics in patients with hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antialbuminuric effect of eplerenone in comparison to thiazide diuretics in patients with hypertension

Published:2017-08-28 Issue:10 Volume:19 Page:990-998
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Sawai Toshiki¹,Dohi Kaoru¹,Fujimoto Naoki¹,Okubo Setsuya²,Isaka Naoki³,Ichikawa Takehiko²,Makino Katsutoshi⁴,Okamoto Shinya⁵,Koyabu Sukenari⁶,Kitamura Tetsuya⁷,Ogura Toru⁸,Yamada Tomomi⁹,Tamaru Satoshi⁸,Nishikawa Masakatsu⁸,Nakamura Mashio¹,Ito Masaaki¹^ORCID,

Affiliation:

1. Department of Cardiology and Nephrology; Mie University Graduate School of Medicine; Tsu Japan

2. Kuwana East Medical Center; Kuwana Japan

3. Murase Hospital; Suzuka Japan

4. Mie Prefectural General Medical Center; Yokkaichi Japan

5. Iwasaki Hospital; Tsu Japan

6. Owase General Hospital; Owase Japan

7. Suzuka General Hospital; Suzuka Japan

8. Clinical Research Support Center; Mie University Hospital; Tsu Japan

9. Department of Medical Innovation; Osaka University Hospital; Suita Japan

Funder

Pfizer Japan

Bristol-Myers Squibb

Astellas Pharma

Biotronik

Genzyme

Shionogi

Dainippon Sumitomo Pharma

Mitsubishi Tanabe Pharma Corporation

Otsuka Pharmaceutical

Bayer

AstraZeneca

Meso Scale Diagnostics

Boehringer Ingelheim

Daiichi-Sankyo

Mochida Pharmaceutical Company

Goodman Co., Ltd.

Kaneka Medix Corp.

Orbusneich Medical K.K.

Biosensors Japan Co., Ltd.,

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.13054/fullpdf

Reference34 articles.

1. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention;Sarnak;Circulation,2003

2. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90;Nakamura;Circ J,2006

3. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

4. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population;Irie;Kidney Int,2006

5. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis;Casas;Lancet,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study;The Journal of Clinical Hypertension;2023-08-07

2. Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis;International Journal of Hypertension;2023-03-09

3. Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus;Frontiers in Endocrinology;2023-02-13

4. Eplerenone–A novel Mineralocorticoid receptor antagonist for the clinical application;Environmental Disease;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3